Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Oakman, Catherine
48  Ergebnisse:
Personensuche X
?
1

Inhibition of lysine acetyltransferase KAT6 in ER+HER2− met..:

Mukohara, Toru ; Park, Yeon Hee ; Sommerhalder, David...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

Author Correction: Inhibition of lysine acetyltransferase K..:

Mukohara, Toru ; Park, Yeon Hee ; Sommerhalder, David...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
3

Palbociclib plus letrozole as treatment for postmenopausal ..:

Loi, Sherene ; Karapetis, Christos S. ; McCarthy, Nicole...
Asia-Pacific Journal of Clinical Oncology.  18 (2021)  6 - p. 560-569 , 2021
Link: https://doi.org/10.1111/..
 
?
4

Assessing the usefulness and acceptability of a low health ..:

Peate, Michelle ; Smith, Sian Karen ; Pye, Victoria...
Pilot and Feasibility Studies.  3 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
5

Serum metabolomic profiles evaluated after surgery may iden..:

Tenori, Leonardo ; Oakman, Catherine ; Morris, Patrick G....
Molecular Oncology.  9 (2014)  1 - p. 128-139 , 2014
Link: https://doi.org/10.1016/..
 
?
6

Exploration of serum metabolomic profiles and outcomes in w..:

Tenori, Leonardo ; Oakman, Catherine ; Claudino, Wederson M....
Molecular Oncology.  6 (2012)  4 - p. 437-444 , 2012
Link: https://doi.org/10.1016/..
 
?
7

Targeting Metabolomics in Breast Cancer:

Oakman, Catherine ; Tenori, Leonardo ; Cappadona S, Silvia...
Current Breast Cancer Reports.  4 (2012)  4 - p. 249-256 , 2012
Link: https://doi.org/10.1007/..
 
?
8

Prognostic and predictive value of TP53mutations in node-po..:

Fernández-Cuesta, Lynnette ; Oakman, Catherine ; Falagan-Lotsch, Priscila...
Breast Cancer Research.  14 (2012)  3 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
9

Inter- and intra-tumoral heterogeneity in DNA damage evalua..:

Galardi, Francesca ; Oakman, Catherine ; Truglia, Maria Caterina...
The Breast.  21 (2012)  3 - p. 336-342 , 2012
Link: https://doi.org/10.1016/..
 
?
10

Triple negative breast cancer: a heterogeneous subgroup den..:

Oakman, Catherine ; Moretti, Erica ; Pacini, Giulia..
European Journal of Cancer.  47 (2011)  - p. S370-S372 , 2011
Link: https://doi.org/10.1016/..
 
?
11

Predictive molecular markers of anthracycline effectiveness..:

Di Leo, Angelo ; Moretti, Erica ; Oakman, Catherine..
European Journal of Cancer Supplements.  9 (2011)  2 - p. 16-21 , 2011
Link: https://doi.org/10.1016/..
 
?
12

Uncovering the metabolomic fingerprint of breast cancer:

Oakman, Catherine ; Tenori, Leonardo ; Biganzoli, Laura...
The International Journal of Biochemistry & Cell Biology.  43 (2011)  7 - p. 1010-1020 , 2011
Link: https://doi.org/10.1016/..
 
?
13

Management of Aromatase Inhibitor-Resistant Disease with Es..:

Oakman, Catherine ; Santarpia, Libero ; Moretti, Erica..
Current Breast Cancer Reports.  3 (2011)  1 - p. 24-33 , 2011
Link: https://doi.org/10.1007/..
 
?
14

Adjuvant systemic treatment for individual patients with tr..:

Oakman, Catherine ; Moretti, Erica ; Galardi, Francesca...
The Breast.  20 (2011)  - p. S135-S141 , 2011
Link: https://doi.org/10.1016/..
 
?
15

Management of triple negative breast cancer:

Oakman, Catherine ; Viale, Giuseppe ; Di Leo, Angelo
The Breast.  19 (2010)  5 - p. 312-321 , 2010
Link: https://doi.org/10.1016/..
 
1-15